RCC-41-PDX-1/CD132+-1.1 induced the formation of tumors within 3 weeks in 5 out of 6 mice at both cell concentrations, indicating the acquisition of an increased tumor forming efficiency at the lower cell concentration. Here, PODXL is linked to neoplasm.